PATIENT OUTCOMES AFTER CORONARY ANGIOPLASTY WITH STENT IMPLANTATION AND STRATEGIES FOR RECURRENCE PROPHYLAXIS: A RETROSPECTIVE COHORT STUDY FROM FERGANA

Main Article Content

Abstract:

This retrospective cohort study analyzes clinical outcomes of 96 patients who underwent percutaneous coronary intervention (PCI) with stent implantation following acute myocardial infarction at the Fergana Regional Cardiology Center. Drug-eluting stents demonstrated significantly lower risks of in-stent restenosis and recurrent myocardial infarction compared with bare-metal stents. Long-term adherence to dual antiplatelet therapy and statin use markedly reduced the incidence of major adverse cardiac events. Diabetes mellitus was identified as a major prognostic factor associated with recurrence. The findings highlight the importance of personalized pharmacological prevention and patient adherence to secondary prophylaxis for improving post-PCI outcomes.

Article Details

How to Cite:

Kurbonov, Y. ., Yuldashev, J. ., & Rakhmonov , K. . (2025). PATIENT OUTCOMES AFTER CORONARY ANGIOPLASTY WITH STENT IMPLANTATION AND STRATEGIES FOR RECURRENCE PROPHYLAXIS: A RETROSPECTIVE COHORT STUDY FROM FERGANA. Eurasian Journal of Medical and Natural Sciences, 5(11), 210–214. Retrieved from https://in-academy.uz/index.php/EJMNS/article/view/66566

References:

A Abrantes, Ana Beatriz Andrêo Garcia, A M Martins, C Gregorio, M Raposo, João Quinta da Fonseca, J Cravo, Alda Jordão, S Fiuza, Eliana Amaro de Carvalho Caldeira, Nélson Cunha, I Aguiar-Ricardo, Francisco José Maia Pinto, & Ana Abreu. (2024). Secondary prevention in young patients after acute ST segment elevation myocardial infarction: Missing the goals and suffering the penalties. European Journal of Preventive Cardiology, 31(Supplement_1). https://doi.org/10.1093/eurjpc/zwae175.426

Alben Sigamani & Rajeev Gupta. (2022). Revisiting secondary prevention in coronary heart disease. Indian Heart Journal, 74(6), 431–440. https://doi.org/10.1016/j.ihj.2022.11.011

Evidence‐Based Optimal Medical Therapy and Mortality in Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention. (2023). Journal of the American Heart Association, 12(10). https://doi.org/10.1161/jaha.121.024370

Fitilev, S. B., Vozzhaev, A. V., Shkrebniova, I. I., Klyuev, D. A., Ovaeva, A. O., & Barsukova, D. K. (2025). Adherence to dual antiplatelet therapy among outpatients after acute myocardial infarction in primary care. Research Results in Pharmacology, 11(3), 26–36. https://doi.org/10.18413/rrpharmacology.11.752

Jirong Xu. (2023). Effectiveness of an AI-Based Secondary Prevention Management Model for Coronary Heart Disease on the Prognosis of Patients After Coronary Intervention For Acute Myocardial Infarction: A Randomized Controlled Trial (Preprint). https://doi.org/10.2196/preprints.55326

Mourikis, P., & Polzin, A. (2023). Dual‐Antiplatelet Therapy After Percutaneous Coronary Intervention: How Short Is Too Short? Journal of the American Heart Association, 12(2), e028775. https://doi.org/10.1161/JAHA.122.028775

Mujeebur Rahman Khan, Ayesha Siddiqui, Mehtab Begum Siddiqui, Syeda Samia Shams, Aisha Alyassi, B. Ali, Abdul Mateen Soomro, Muhammad Saif-ur Rehman, & Ezaa Javed. (2024). Evaluating the efficacy of statins, aspirin, and antihypertensive therapy in preventing recurrent cardiovascular events in post-myocardial infarction patients: A meta-analysis. 2(2 (Health&Rehab)), 201–208. https://doi.org/10.71000/ijhr155

Nicholas Nguyen & K Michelis. (2025). Pharmacotherapy, Lifestyle Modification, and Cardiac Rehabilitation after Myocardial Infarction or Percutaneous Intervention. US Cardiology, 19. https://doi.org/10.15420/usc.2024.34

Ravshan o'g'li, K. S., & Mavlonjon o’g’li, Q. J. (2024). Review Of The Use Of Tomosynthesis For The Diagnosis Of Injuries And Diseases Of The Musculoskeletal System. Frontiers in Health Informatics, 13(6).

Ravshan o'g'li, K. S., & Mavlonjon o’g’li, Q. J. (2024). Review Of The Use Of Tomosynthesis For The Diagnosis Of Injuries And Diseases Of The Musculoskeletal System. Frontiers in Health Informatics, 13(6).

Sadriddin, P., Akhtam, R., Mahbuba, A., Sherzod, K., Gulnora, R., Orif, N., ... & Olimjon, J. Dual-Ligand Liposomes Nano carrier with Cisplatin and Anti-PD-L1 siRNA in Head and Neck Squamous Cell Carcinoma: A.

Кенжаев, Ш. (2025). MANAGEMENT OF FRAGILITY FRACTURES IN THE ELDERLY: FROM PREVENTION TO SURGICAL INTERVENTION. Международный мультидисциплинарный журнал исследований и разработок, 1(4), 979-983.